Xiang-Yu Zhang

Xiang-Yu Zhang is a Lead Financial Analyst in RNA Therapeutics at Houston Methodist since June 2023, responsible for managing finances for the RNA Core, retrieving lost revenue exceeding $50,000, handling quoting and invoicing, collaborating with project and operations managers to enhance processes, supporting financial cycle processes, and serving as the primary contact for financial projects. Prior to this role, Zhang worked as an Assurance Staff at EY from November 2021 to January 2023, where responsibilities included supporting assurance engagements, documenting audit procedures, maintaining flexibility across multiple tasks, and utilizing data analytics tools for auditing. Xiang-Yu Zhang holds a degree from the University of Houston, earned between 2017 and 2020.